APAC Hepatitis Therapeutics Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 4990

  • Format: PPT, PDF

APAC Hepatitis Therapeutics Market Analysis: Segmented by Diseases Type, Drug Class, Distribution Channel- Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

Clear
SKU: 4990 Categories: ,

Report Description of the APAC Hepatitis Therapeutics Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC Hepatitis Therapeutics   Market  Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Hepatitis Therapeutics   Market  Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Hepatitis Therapeutics Market Analysis Executive Summary

Hepatitis is caused due to different infections known as infection A, infection B, infection C, infection D, infection E and infection G. The disease prompts irritation of liver tissues, which can trigger liver cirrhosis and malignant growth. The disease decreases liver capacity and harm to other body capacities. Hepatitis can be acute and chronic both. Among every one of the kinds, hepatitis B and C are the most hazardous and hard to treat.

Market Size and Key Findings

The APAC Hepatitis Therapeutics Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 5.8% during the forecast period.

The Asia Pacific market is expected to witness the fastest growth rate of 5.8% over the forecast period. High disease burden, growing access to medicines, improvement in healthcare & sanitation, and rising awareness about the hepatitis vaccination are expected to positively reinforce the growth prospects in the region. For instance, countries such as India, China, Indonesia, and other South Asian economies are constantly increasing their healthcare expenditure and reimbursement coverage to help more people avail quality healthcare services.

Market Dynamics

Market Growth Drivers Analysis

The development of the hepatitis therapeutics market is driven by ascend in commonness of different hepatitis, expanding research and development work, clinical preliminaries of hepatitis drugs, expansion in number of item endorsements and product launches and development of novel hepatitis drugs in the treatment of different kinds of hepatitis. Increasing research coordinated efforts for the development of powerful medications in pipeline drives the market growth significantly. Besides, associations and joint effort in significant organizations ascend in persistent mindfulness in regards to hepatitis therapeutics treatment, and presentation of low-estimated hepatitis therapeutics is different variables that support the development of the market.

Market Restraints

Significant expense of hepatitis drugs is relied upon to limit the development of the hepatitis therapeutics market.

COVID-19 impact on “APAC Hepatitis Therapeutics Market”

The outbreak of COVID-19 has disrupted workflows in the healthcare sector across the world. The disease has forced a number of industries to shut their doors temporarily, including several sub-domains of healthcare. Concerns were identified with the security and viability of COVID-19 antibodies for individuals living with hepatitis B and liver illness. In 2020, the COVID-19 pandemic disturbed the whole HCV benefits worldwide, with 25% fewer patients being started on treatment than in 2019. Hence, the overall impact of COVID-19 on hepatitis therapeutics market is positive, which will further drive the market growth.

Competitive Landscape

Key Players

The key market players profiled in the report include Abbvie Inc., Bristol Myers & Squibb, Cipla Inc., Gilead Sciences Inc., GlaxoSmithKline Plc, Hoffmann-La Roche Ltd., Lupin Ltd., Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., and Zydus Cadila.

Products in Pipeline

The hepatitis C market is currently dominated by highly efficacious DAAs. Sovaldi (sofosbuvir), Gilead’s pan-genotypic HCV polymerase (NS5B) inhibitor, has been the cornerstone of the market for the last two years in the Asia-Pacific region. This success illustrates the importance of providing a drug with an excellent efficacy profile for the majority of patient groups simultaneously.

Notable Recent Deals

  • Gilead has licensed 7 Indian manufacturers to supply some of the hepatitis drugs to different parts of the world. The countries covered as a part of this deal include more than 50% of the HCV infected population.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

National governments can play an important role in making their citizens aware of the importance of viral hepatitis, how to avoid getting infected and how to seek care. World Hepatitis Day (28 July), which was established in 2010 as part of the World Health Assembly resolution 63.18, is an important means of raising awareness about hepatitis. Two years after the passage of the resolution, almost 40% of responding Member States reported that they had engaged in activities to mark World Hepatitis Day. However, it is important for the remaining Member States, particularly where the burden of viral hepatitis is high, to organize World Hepatitis Day activities. Civil society organizations can play a significant role in further publicizing health messages for World Hepatitis Day and throughout the year. However, less than half of responding Member States reported that they collaborated with civil society groups within their countries to develop and implement the governmental viral hepatitis prevention and control programme.

1. Report Description of the APAC Hepatitis Therapeutics Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Hepatitis Therapeutics Market Analysis Executive Summary
2.1 APAC Hepatitis Therapeutics Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Hepatitis Therapeutics Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Ascend in commonness of different hepatitis
3.1.2 Expanding research and development work
3.2 Market Restraints Analysis
3.2.1 Significant expense of hepatitis drugs
3.3 Covid-19 Market Impact Analysis
4. APAC Hepatitis Therapeutics Market Segmentation
4.1 By Disease Type:
4.1.1 Hepatitis B
4.1.2 Hepatitis C
4.1.3 Others (A, D, E and G)
4.2 By Drug Class:
4.2.1 Oral Antivirals
4.2.2 Immune Modulators
4.3 By Distribution Channel:
4.3.1 Hospital Pharmacies
4.3.2 Drug Stores & Retail Pharmacies
4.3.3 Online Providers
5. APAC Hepatitis Therapeutics Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Hepatitis Therapeutics Market
6.4 Notable recent deals in Hepatitis Therapeutics Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Abbvie Inc. Company overview
Product & Services, Strategies & Financials
7.2 Bristol Mayers & Squibb Company overview
Product & Services, Strategies & Financials
7.3 Lupin Ltd. Company overview
Product & Services, Strategies & Financials
7.4 Cipla Inc. Company overview
Product & Services, Strategies & Financials
7.5 Gilead Sciences Inc. Company overview
Product & Services, Strategies & Financials
7.6 GlaxoSimithKline Plc Company overview
Product & Services, Strategies & Financials
7.7 Hoffmann-La Roche Ltd. Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Hepatitis Therapeutics market
9.2 Future Opportunities
10. Strategic Recommendations

APAC Hepatitis Therapeutics Market Analysis Segmentation

By Disease Type:

On the basis of disease type, the market is further classified into hepatitis B, hepatitis C, and others (hepatitis A, D, E and G). By disease type, the hepatitis C segment accounted for the largest share of the hepatitis therapeutics market in 2020. The large share of this segment can be attributed to the increasing prevalence of hepatitis C and rising product approvals by regulatory authorities.

By Drug Class:

By drug class, it is divided into oral antivirals, and immune modulators.

By Distribution Channel:

Based on distribution channel, it is subdivided in to hospital pharmacies, drug stores and retail pharmacies, and online providers. Further, drug stores & retail pharmacies segment is anticipated to depict largest growth during the forecast period, due to increasing drug availability of both branded and generics. In addition, online providers are expected to witness fastest growth owing to the lucrative discount offers provided by the online providers, which is expected to attract more customers to opt for online provider’s services.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements